Jackson Grant Investment Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Jackson Grant Investment Advisers’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.8K	Hold	500	–	–	0.03%	159
2025 Q4	$94.5K	Hold	500	–	–	0.03%	162
2025 Q3	$88.6K	Hold	500	–	–	0.03%	163
2025 Q2	$56.8K	Hold	500	–	–	0.02%	174
2025 Q1	$52.6K	Hold	500	–	–	0.02%	173
2024 Q4	$53.6K	Hold	500	–	–	0.02%	174
2024 Q3	$50K	Hold	500	–	–	0.02%	181
2024 Q2	$42.1K	Hold	500	–	–	0.02%	191
2024 Q1	$36.5K	Hold	500	–	–	0.02%	190
2023 Q4	$35.7K	Hold	500	–	–	0.02%	191
2023 Q3	$30K	Hold	500	–	–	0.01%	201
2023 Q2	$36K	Hold	500	–	–	0.02%	188
2023 Q1	$36.8K	Hold	500	–	–	0.02%	205
2022 Q4	$33.4K	Sell	500 -302	-38%	-$19.6K	0.02%	213
2022 Q3	$43K	Hold	802	–	–	0.02%	185
2022 Q2	$45K	Hold	802	–	–	0.02%	191
2022 Q1	$56K	Hold	802	–	–	0.02%	187
2021 Q4	$77K	Hold	802	–	–	0.04%	138
2021 Q3	$70K	Hold	802	–	–	0.03%	177
2021 Q2	$66K	Hold	802	–	–	0.03%	176
2021 Q1	$76K	Hold	802	–	–	0.04%	165
2020 Q4	$50K	Hold	802	–	–	0.03%	184
2020 Q3	$48K	Hold	802	–	–	0.03%	149
2020 Q2	$56K	Hold	802	–	–	0.04%	136
2020 Q1	$36K	Hold	802	–	–	0.03%	151
2019 Q4	$52K	Hold	802	–	–	0.03%	147
2019 Q3	$50K	Hold	802	–	–	0.03%	148
2019 Q2	$57K	Hold	802	–	–	0.03%	141
2019 Q1	$63K	Hold	802	–	–	0.04%	134
2018 Q4	$68K	Hold	802	–	–	0.05%	130
2018 Q3	$137K	Buy	+802	New	+$121K	0.09%	102

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Jackson Grant Investment Advisers's LGND Position: Q1 2026 in Review

Jackson Grant Investment Advisers held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 500 shares worth $99.8K. The position accounts for 0.03% of the portfolio, ranked #159.

Jackson Grant Investment Advisers first reported a position in LGND in Q3 2018 and has held it in 31 quarters since. The position peaked at $137K in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Jackson Grant Investment Advisers held 500 shares of Ligand Pharmaceuticals worth $99.8K as of Q1 2026.
Jackson Grant Investment Advisers left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
Ligand Pharmaceuticals made up 0.03% of Jackson Grant Investment Advisers's portfolio in Q1 2026, its #159 holding.
Jackson Grant Investment Advisers first reported a position in Ligand Pharmaceuticals in Q3 2018 and has held it in 31 quarters since.
Jackson Grant Investment Advisers's Ligand Pharmaceuticals position peaked at $137K in Q3 2018.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2026, filed 8 May 2026.